{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:48:48Z","timestamp":1794440928714,"version":"4.9.1"},"reference-count":32,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>A growing body of evidence points to a role for herpesviruses in the development of Alzheimer\u2019s disease (AD) and a reduced risk of AD among patients receiving antiherpetic medications. We investigated the association between herpes simplex virus type 1 (HSV-1) and AD using real-world data (RWD) from USA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>In a matched case\u2013control study, patients with AD aged \u226550 years diagnosed between 2006 and 2021 were identified from the IQVIA PharMetrics Plus claims database. Controls were matched in a 1:1 ratio with subjects with AD on age, sex, region, database entry year and healthcare visit numbers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 344\u2009628 AD case\u2013control pairs. History of HSV-1 diagnosis was present in 1507 (0.44%) patients with AD compared with 823 (0.24%) controls. HSV-1 diagnosis was found to be associated with AD (adjusted OR 1.80; 95% CI 1.65 to 1.96). Patients with HSV-1 who used antiherpetics were less likely to develop AD compared with those who did not use antiherpetics (adjusted HR 0.83, 95%\u2009CI 0.74 to 0.92).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings from this large RWD study implicate HSV-1 in the development of AD and highlight antiherpetic therapies as potentially protective for AD and related dementia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-093946","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T16:22:28Z","timestamp":1747844548000},"page":"e093946","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Association between herpes simplex virus type 1 and the risk of Alzheimer\u2019s disease: a retrospective case\u2013control study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8844-1270","authenticated-orcid":false,"given":"Yunhao","family":"Liu","sequence":"first","affiliation":[{"name":"Gilead Sciences Inc, Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Jarousse","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"2025121404092979000_15.5.e093946.1","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.12328"},{"key":"2025121404092979000_15.5.e093946.2","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2020.88482"},{"key":"2025121404092979000_15.5.e093946.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3040"},{"key":"2025121404092979000_15.5.e093946.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"key":"2025121404092979000_15.5.e093946.5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-140822","article-title":"Herpes Viruses Increase the Risk of Alzheimer\u2019s Disease: A Meta-Analysis","volume":"47","author":"Steel","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2025121404092979000_15.5.e093946.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.04.522"},{"key":"2025121404092979000_15.5.e093946.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.157"},{"key":"2025121404092979000_15.5.e093946.8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-142853","article-title":"Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer\u2019s Disease","volume":"48","author":"Harris","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2025121404092979000_15.5.e093946.9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00324"},{"key":"2025121404092979000_15.5.e093946.10","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.19.237149"},{"key":"2025121404092979000_15.5.e093946.11","doi-asserted-by":"crossref","unstructured":"Wald A , Corey L , et al . Persistence in the population: epidemiology, transmission, in human herpesviruses: biology, therapy. 2007.","DOI":"10.1017\/CBO9780511545313.037"},{"key":"2025121404092979000_15.5.e093946.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007617","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice","volume":"15","author":"De Chiara","year":"2019","journal-title":"PLoS Pathog"},{"key":"2025121404092979000_15.5.e093946.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.06.030"},{"key":"2025121404092979000_15.5.e093946.14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025121404092979000_15.5.e093946.15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay8828","article-title":"A 3D human brain-like tissue model of herpes-induced Alzheimer\u2019s disease","volume":"6","author":"Cairns","year":"2020","journal-title":"Sci Adv"},{"key":"2025121404092979000_15.5.e093946.16","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.12.81"},{"key":"2025121404092979000_15.5.e093946.17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/infdis\/jiz560","article-title":"Varicella-Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-\u03b2, and an Amyloidogenic Extracellular Environment","volume":"221","author":"Bubak","year":"2020","journal-title":"J Infect Dis"},{"key":"2025121404092979000_15.5.e093946.18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-021-00950-0","article-title":"Antiherpetic drugs: a potential way to prevent Alzheimer\u2019s disease?","volume":"14","author":"Linard","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"2025121404092979000_15.5.e093946.19","doi-asserted-by":"crossref","DOI":"10.1002\/trc2.12119","article-title":"Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden","volume":"7","author":"Lopatko Lindman","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"2025121404092979000_15.5.e093946.20","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-0611-x"},{"key":"2025121404092979000_15.5.e093946.21","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11312","article-title":"Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study","volume":"79","author":"Chen","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"2025121404092979000_15.5.e093946.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188490","article-title":"Increased risk of dementia following herpes zoster ophthalmicus","volume":"12","author":"Tsai","year":"2017","journal-title":"PLoS One"},{"key":"2025121404092979000_15.5.e093946.23","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s13311-021-01084-9","article-title":"Symptomatic Herpes Simplex Virus Infection and Risk of Dementia in US Veterans: a Cohort Study","volume":"18","author":"Young-Xu","year":"2021","journal-title":"Neurotherapeutics"},{"key":"2025121404092979000_15.5.e093946.24","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1185\/03007995.2013.847411","article-title":"Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis","volume":"29","author":"Bergvall","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"2025121404092979000_15.5.e093946.25","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2012-000896"},{"key":"2025121404092979000_15.5.e093946.26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-160105","article-title":"Identification of Physician-Diagnosed Alzheimer\u2019s Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians\u2019 Electronic Medical Records","volume":"54","author":"Jaakkimainen","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2025121404092979000_15.5.e093946.27","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311336"},{"key":"2025121404092979000_15.5.e093946.28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-150652","article-title":"Protective Effect of Amyloid-\u03b2 Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model","volume":"50","author":"Bourgade","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2025121404092979000_15.5.e093946.29","doi-asserted-by":"publisher","DOI":"10.1002\/path.2449"},{"key":"2025121404092979000_15.5.e093946.30","doi-asserted-by":"crossref","first-page":"15444","DOI":"10.1038\/srep15444","article-title":"Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-\u03b2 protein accumulation","volume":"5","author":"Piacentini","year":"2015","journal-title":"Sci Rep"},{"key":"2025121404092979000_15.5.e093946.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10149-5"},{"key":"2025121404092979000_15.5.e093946.32","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.039735"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-093946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:09:41Z","timestamp":1765714181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-093946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,20]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2024-093946"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093946","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093946.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}